Esther Rajavelu - Nov 7, 2024 Form 4 Insider Report for Spero Therapeutics, Inc. (SPRO)

Role
CFO & CBO
Signature
Maegan Deare, attorney-in-fact for Esther Rajavelu
Stock symbol
SPRO
Transactions as of
Nov 7, 2024
Transactions value $
-$53,008
Form type
4
Date filed
11/12/2024, 04:05 PM
Previous filing
Feb 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRO Common Stock Sale -$30.6K -23.4K -5.56% $1.31 397K Nov 7, 2024 Direct F1
transaction SPRO Common Stock Sale -$22.4K -17.2K -4.35% $1.30 379K Nov 8, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a "sell to cover" provision included in each RSU Agreement in connection with the vesting of RSUs that were granted to the Reporting Person on November 13, 2023.